[Development of heart failure after myocardial infarct: changes in plasma renin activity, angiotensin II, catecholamines and atrial natriuretic peptide].
Kleber
F X
FX
Krankenhaus München-Schwabing, Ludwig-Maximilians-Universität München, FRG.
Nussberger
J
J
Niemöller
L
L
Doering
W
W
Brunner
H
H
D000804:Angiotensin II / Q000097:blood*; D009320:Atrial Natriuretic Factor / Q000097:blood*; D002216:Captopril / Q000627:therapeutic use; D002395:Catecholamines / Q000097:blood*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology*; D012083:Renin / Q000097:blood*; D016277:Ventricular Function, Left / Q000187:drug effects / Q000502:physiology
D002395:Catecholamines; D000804:Angiotensin II; D009320:Atrial Natriuretic Factor; D002216:Captopril; D012083:Renin
Entwicklung der Herzinsuffizienz nach Myokardinfarkt: Veränderungen von Plasma-Reninaktivität, Angiotensin II, Katecholaminen und atrialem natriuretischen Peptid.